- Home
- EVTV vs EVAX Comparison
EVTV vs EVAX Comparison
Compare EVTV & EVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVTV
- EVAX
- Stock Information
- Founded
- EVTV 2012
- EVAX 2008
- Country
- EVTV United States
- EVAX Denmark
- Employees
- EVTV N/A
- EVAX N/A
- Industry
- EVTV Auto Manufacturing
- EVAX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- EVTV Consumer Discretionary
- EVAX Health Care
- Exchange
- EVTV Nasdaq
- EVAX Nasdaq
- Market Cap
- EVTV 6.2M
- EVAX 17.8M
- IPO Year
- EVTV 2017
- EVAX 2021
- Fundamental
- Price
- EVTV $2.10
- EVAX $2.93
- Analyst Decision
- EVTV
- EVAX Strong Buy
- Analyst Count
- EVTV 0
- EVAX 2
- Target Price
- EVTV N/A
- EVAX $10.00
- AVG Volume (30 Days)
- EVTV 886.3K
- EVAX 68.5K
- Earning Date
- EVTV 11-13-2025
- EVAX 10-30-2025
- Dividend Yield
- EVTV N/A
- EVAX N/A
- EPS Growth
- EVTV N/A
- EVAX N/A
- EPS
- EVTV N/A
- EVAX N/A
- Revenue
- EVTV $1,884,395.00
- EVAX $3,176,000.00
- Revenue This Year
- EVTV N/A
- EVAX N/A
- Revenue Next Year
- EVTV N/A
- EVAX $425.50
- P/E Ratio
- EVTV N/A
- EVAX N/A
- Revenue Growth
- EVTV 2.97
- EVAX 1042.45
- 52 Week Low
- EVTV $1.50
- EVAX $1.20
- 52 Week High
- EVTV $21.30
- EVAX $16.69
- Technical
- Relative Strength Index (RSI)
- EVTV 46.47
- EVAX 51.89
- Support Level
- EVTV $2.02
- EVAX $2.81
- Resistance Level
- EVTV $5.07
- EVAX $3.04
- Average True Range (ATR)
- EVTV 0.51
- EVAX 0.21
- MACD
- EVTV -0.02
- EVAX -0.00
- Stochastic Oscillator
- EVTV 4.95
- EVAX 68.64
About EVTV Envirotech Vehicles Inc.
Envirotech Vehicles Inc is a provider of purpose-built zero-emission electric vehicles focused on reducing the total cost of vehicle ownership and helping fleet operators unlock the benefits of green technology. It recognizes revenue from the sales of zero-emission electric vehicles and vehicle maintenance and inspection services. The Company serves commercial and last-mile fleets, school districts, public and private transportation service companies and colleges and universities to meet the increasing demand for light to heavy-duty electric vehicles.
About EVAX Evaxion Biotech
Evaxion AS is a techBio company based on its AI platform, AI-Immunology. Evaxion's proprietary and scalable AI prediction models harness the power of artificial intelligence to decode the human immune system and develop novel immunotherapies for cancer, bacterial diseases, and viral infections. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing innovative and targeted treatment options.